Huntington National Bank Oyster Point Pharma, Inc. Transaction History

Huntington National Bank

$12.7 Billion
Q2 2024

A detailed history of Huntington National Bank transactions in Oyster Point Pharma, Inc. stock. As of the latest transaction made, Huntington National Bank holds 1 shares of OYST stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.0 - $11.17 $0 - $9,997	-895 Reduced 99.89%	1 $0
Q4 2022 Feb 09, 2023	BUY	$7.95 - $11.68 $659 - $969	83 Added 10.21%	896 $10,000
Q3 2022 Nov 07, 2022	SELL	$4.41 - $8.38 $1,428 - $2,715	-324 Reduced 28.5%	813 $5,000
Q2 2022 Aug 09, 2022	BUY	$3.6 - $11.2 $3,596 - $11,188	999 Added 723.91%	1,137 $5,000
Q1 2022 May 10, 2022	BUY	$8.58 - $17.65 $128 - $264	15 Added 12.2%	138 $2,000
Q4 2021 Jan 21, 2022	BUY	$10.17 - $18.96 $1,250 - $2,332	123 New	123 $2,000

Others Institutions Holding OYST

# of Institutions

Shares Held

19K

Call Options Held

Put Options Held

View Full List

About Oyster Point Pharma, Inc.

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

More about OYST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Oyster Point Pharma, Inc. Transaction History